statistiche ricercatore

FASANO, MAURO

Distribuzione geografica

Continente	#
NA - Nord America	20.125
EU - Europa	9.873
AS - Asia	5.785
SA - Sud America	549
Continente sconosciuto - Info sul continente non disponibili	151
AF - Africa	126
OC - Oceania	11
Totale	36.620

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	19.872
IT - Italia	4.563
SG - Singapore	1.954
UA - Ucraina	1.481
CN - Cina	1.192
DE - Germania	851
VN - Vietnam	842
SE - Svezia	798
TR - Turchia	716
HK - Hong Kong	653
FI - Finlandia	488
GB - Regno Unito	453
BR - Brasile	440
IE - Irlanda	390
FR - Francia	301
RU - Federazione Russa	223
IN - India	113
CA - Canada	107
MX - Messico	91
BD - Bangladesh	79
JP - Giappone	69
NG - Nigeria	51
BE - Belgio	50
ES - Italia	44
NL - Olanda	44
PL - Polonia	44
CZ - Repubblica Ceca	39
AR - Argentina	36
ZA - Sudafrica	35
KR - Corea	19
EU - Europa	18
PK - Pakistan	18
IQ - Iraq	17
AT - Austria	16
PE - Perù	15
CO - Colombia	13
CL - Cile	12
JM - Giamaica	12
CH - Svizzera	11
CR - Costa Rica	11
VE - Venezuela	11
ID - Indonesia	10
LT - Lituania	10
SA - Arabia Saudita	10
EC - Ecuador	9
NP - Nepal	9
PH - Filippine	9
DK - Danimarca	8
EG - Egitto	8
IL - Israele	8
PT - Portogallo	8
RO - Romania	8
UZ - Uzbekistan	8
AE - Emirati Arabi Uniti	7
AU - Australia	7
MD - Moldavia	7
MY - Malesia	7
PY - Paraguay	7
BG - Bulgaria	6
ET - Etiopia	6
HU - Ungheria	6
JO - Giordania	6
MA - Marocco	6
NI - Nicaragua	6
TN - Tunisia	6
DZ - Algeria	5
HN - Honduras	5
HR - Croazia	5
IR - Iran	5
OM - Oman	5
SV - El Salvador	5
EE - Estonia	4
GR - Grecia	4
KZ - Kazakistan	4
NZ - Nuova Zelanda	4
TH - Thailandia	4
BO - Bolivia	3
DO - Repubblica Dominicana	3
KE - Kenya	3
LB - Libano	3
SI - Slovenia	3
UY - Uruguay	3
AM - Armenia	2
AZ - Azerbaigian	2
BH - Bahrain	2
BZ - Belize	2
GT - Guatemala	2
MM - Myanmar	2
NO - Norvegia	2
PR - Porto Rico	2
QA - Qatar	2
RS - Serbia	2
SY - Repubblica araba siriana	2
TT - Trinidad e Tobago	2
TW - Taiwan	2
AL - Albania	1
BS - Bahamas	1
CG - Congo	1
CI - Costa d'Avorio	1
GE - Georgia	1
Totale	36.473

Salva come PNG Salva come JPEG

Città	#
Milan	2.930
Fairfield	2.486
Ashburn	1.610
Woodbridge	1.475
Chandler	1.265
San Jose	1.185
Jacksonville	1.141
Singapore	1.113
Seattle	1.021
Houston	1.012
Cambridge	888
Wilmington	857
Hong Kong	648
Ann Arbor	624
Dearborn	459
Princeton	406
Dallas	386
Council Bluffs	384
Dublin	380
Beijing	341
Nyköping	335
Izmir	329
The Dalles	317
Chicago	316
Boardman	277
Rome	252
Dong Ket	240
Como	230
Lauterbourg	182
Munich	182
Los Angeles	157
San Mateo	149
New York	142
Ho Chi Minh City	112
San Diego	111
Santa Clara	109
Helsinki	105
Hanoi	97
Ogden	80
London	77
Orem	67
Tokyo	62
São Paulo	58
Guangzhou	55
Hefei	52
Mexico City	52
Abuja	51
Varese	50
Brussels	49
Denver	45
Montreal	44
Atlanta	43
Buffalo	42
Warsaw	40
Chennai	36
Kunming	36
Washington	36
Salt Lake City	35
Turku	35
Brooklyn	34
Verona	34
Phoenix	33
Stockholm	33
Nanjing	32
Poplar	30
Falls Church	29
Paris	28
San Francisco	28
Düsseldorf	27
Nanchang	27
Johannesburg	25
Amsterdam	23
Shanghai	23
Frankfurt am Main	22
Olomouc	22
Curitiba	21
Norwalk	21
Ponte Lambro	21
Boston	20
Elk Grove Village	20
Jinan	20
Manchester	19
Berlin	18
Brno	17
Redmond	17
Tampa	17
Columbus	16
Edinburgh	16
Tianjin	16
Cavaria con Premezzo	15
Naples	15
Philadelphia	15
Shenyang	15
Shenzhen	15
Toronto	15
Hangzhou	14
Da Nang	13
Haiphong	12
Mumbai	12
Nuremberg	12
Totale	26.160

Salva come PNG Salva come JPEG

Nome	#
Experimental setup for the identification of mitochondrial protease substrates by shotgun and top-down proteomics	406
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin	403
Changes in the two-dimensional electrophoresis pattern of the Parkinson's disease related protein DJ-1 in human SH-SY5Y neuroblastoma cells after dopamine treatment	376
Dopamine induces mitochondrial depolarization without activating PINK1-mediated mitophagy	292
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex	283
A meta-analysis of two-dimensional electrophoresis pattern of the Parkinson's disease-related protein DJ-1	279
Flavonoid binding to human serum albumin.	264
Mitochondrial Proteins in the Development of Parkinson’s Disease	261
Human serum albumin: from bench to bedside.	256
Cellular models to investigate biochemical pathways in Parkinson's disease	253
Systems biology analysis of the proteomic alterations induced by MPP+, a parkinson's disease-related mitochondrial toxin	252
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex	251
Ibuprofen binding to secondary sites allosterically modulates the spectroscopic and catalytic properties of human serum heme-albumin	250
Evidence for pH-dependent multiple conformers in iron(II) heme-human serum albumin: spectroscopic and kinetic investigation of carbon monoxide binding.	247
Proteome analysis of human substantia nigra in Parkinson's disease	246
Multiple isoforms and differential allelic expression of CHRNA5 in lung tissue and lung adenocarcinoma	239
Binding of anti-Parkinson's disease drugs to human serum albumin is allosterically modulated.	236
Drugs modulate allosterically heme-fe-recognition by human serum albumin and heme-fe-mediated reactivity	235
Allostery in a monomeric protein: the case of human serum albumin.	233
Ibuprofen and warfarin modulate allosterically ferrous human serum heme-albumin nitrosylation.	232
Isoniazid and rifampicin inhibit allosterically heme binding to albumin and peroxynitrite isomerization by heme-albumin.	230
H-1 NMR relaxometric characterization of bovine lactoferrin	228
Sequence analysis of serum albumins reveals the molecular evolution of ligand recognition properties.	224
All-trans-retinoic acid and retinol binding to the FA1 site of human serum albumin competitively inhibits heme-Fe(III) association	224
Exploring the mitochondrial degradome by the TAILS proteomics approach in a cellular model of Parkinson's disease	224
Verification of a parkinsons disease protein signature in T-lymphocytes by multiple reaction monitoring	223
O2-mediated oxidation of ferrous nitrosylated human serum heme-albumin is limited by nitrogen monoxide dissociation.	220
Proteomics as a tool to investigate cell models for dopamine toxicity	218
Lymphocyte proteomics of Parkinson's disease patients reveals cytoskeletal protein dysregulation and oxidative stress	218
Towards a functional definition of the mitochondrial human proteome	218
Abacavir and warfarin modulate allosterically kinetics of NO dissociation from ferrous nitrosylated human serum heme-albumin	217
Allosteric modulation of drug binding to human serum albumin	216
Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease	216
Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg).	215
Metal complexes as allosteric effectors of human hemoglobin: An NMR study of the interaction of the gadolinium(III) bis(m-boroxyphenylamide)diethylenetriaminepentaacetic acid complex with human oxygenated and deoxygenated hemoglobin	214
Thermodynamic analysis of hydration in human serum heme-albumin.	214
Reductive nitrosylation of ferric human serum heme-albumin.	212
Allosteric and binding properties of Asp1-Glu382 truncated recombinant human serum albumin - an optical and NMR spectroscopic investigation	210
Discovery and verification of panels of T-lymphocyte proteins as biomarkers of Parkinson's disease	209
Altered dopamine homeostasis differentially affects mitochondrial voltage-dependent anion channels turnover	209
Systems biology analysis of the proteomic alterations in Parkinson's disease: Common and disease-specific pathways	209
Peripheral biomarkers of Parkinson's disease as early reporters of central neurodegeneration	208
Mitochondrial proteomics investigation of a cellular model of impaired dopamine homeostasis, an early step in Parkinson's disease pathogenesis	206
Deinococcus radiodurans' SRA-HNH domain containing protein Shp (Dr1533) is involved in faithful genome inheritance maintenance following DNA damage	205
Demonstration of fibrinogen-FcRn binding at acidic pH by means of Fluorescence Correlation Spectroscopy	205
Ligand binding to the FA3-FA4 cleft inhibits the esterase-like activity of human serum albumin	204
1H NMR RELAXOMETRIC AND OPTICAL ABSORBANCE CHARACTERIZAZION OF THE INTERACTION OF MANGANESE PORPHYRINS WITH HUMAN SERUM ALBUMIN	203
Heme binding to albuminoid proteins is the result of recent evolution	203
Proteomics and renaissance: accounts of the V Italian Proteomics Association Congress, Florence 2010.	203
A systems biology-led insight into the role of the proteome in neurodegenerative diseases	203
Proteomic characterization of Jurkat T leukemic cells after dopamine stimulation: A model of circulating dopamine-sensitive cells	202
Mitochondrial alterations in Parkinson's disease human samples and cellular models	202
AN NMR-STUDY OF THE INTERACTION BETWEEN MELANIN FREE ACID AND MN2+ IONS AS A MODEL TO MIMIC THE ENHANCED PROTON RELAXATION RATES IN MELANOTIC MELANOMA	201
Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin	200
Diagnostic Salivary Tests for SARS-CoV-2	200
Ibuprofen modulates allosterically NO dissociation from ferrous nitrosylated human serum heme-albumin by binding to three sites.	199
Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies	199
Molecular phylogenetic analyses of albuminoids reveal the molecular evolution of allosteric properties	199
Method for the in vitro diagnosis of parkinson's disease	198
Integrative proteomics: perspective in complex system interpretation.	195
Ibuprofen impairs allosterically peroxynitrite isomerization by ferric human serum heme-albumin.	194
PARAMAGNETIC GD-III-FE-III HETEROBIMETALLIC COMPLEXES OF DTPA-BIS-SALICYLAMIDE	193
Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients	193
Cellular response to empty and palladium-conjugated amino-polystyrene nanospheres uptake: A proteomic study	193
Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study	193
Is neuromelanin changed in Parkinson's disease? Investigations by magnetic spectroscopies	192
Saliva is a reliable tool to detect SARS-CoV-2	192
Isolation and C-13-NMR characterization of an insoluble proteinaceous fraction from substantia nigra of patients with Parkinson's disease	191
Mn(II) binding to human serum albumin: A (1)H-NMR relaxometric study.	190
Saggio rapido per la diagnosi in vitro di infezione da SARS-CoV-2 in un fluido biologico	189
Abacavir modulates peroxynitrite-mediated oxidation of ferrous nitrosylated human serum heme-albumin	188
Toward the Standardization of Mitochondrial Proteomics: The Italian Mitochondrial Human Proteome Project Initiative	188
Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis	187
Pseudo-enzymatic hydrolysis of 4-nitrophenyl myristate by human serum albumin.	187
SYNTHESIS AND CHARACTERIZATION OF A NOVEL DTPA-LIKE GADOLINIUM(III) COMPLEX - A POTENTIAL REAGENT FOR THE DETERMINATION OF GLYCATED PROTEINS BY WATER PROTON NMR RELAXATION MEASUREMENTS	186
The five-to-six-coordination transition of ferric human serum heme-albumin is allosterically-modulated by ibuprofen and warfarin: a combined XAS and MD study.	186
A new ytterbium chelate as contrast agent in chemical shift imaging and temperature sensitive probe for MR spectroscopy	185
EVIDENCE FOR A GLYCIDIC-LIPIDIC MATRIX IN HUMAN NEUROMELANIN, POTENTIALLY RESPONSIBLE FOR THE ENHANCED IRON SEQUESTERING ABILITY OF SUBSTANTIA-NIGRA	184
Parkinson's disease plasma biomarkers: An automated literature analysis followed by experimental validation	184
Prevention and modulation of aminoglycoside ototoxicity (Review)	183
Digital and analogical reality in proteomics investigation	182
Azide, cyanide, fluoride, imidazole and pyridine binding to ferric and ferrous native horse heart cytochrome c and to its carboxymethylated derivative: A comparative study	181
1H-NMR relaxometric analysis of drug binding effects to global unfolding of human serum albumin.	180
Alpha-synuclein and Parkinson's disease: a proteomic view	180
Looking at COVID-19 from a Systems Biology Perspective	179
Stabilization of the T-state of human hemoglobin by proflavine, an antiseptic drug	177
Prototropic and water-exchange processes in aqueous solutions of Gd(III) chelates	177
Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells	177
H-1-NMR relaxometric study of pancreatic serine (pro)enzyme inhibition by a Gd(III) chelate bearing boronic functionalities	176
Serum heme-albumin: an allosteric protein.	176
Metodo per la diagnosi in vitro della malattia di Parkinson	176
Warfarin inhibits allosterically the reductive nitrosylation of ferric human serum heme-albumin	176
The drug-dependent five- to six-coordination transition of the heme-Fe atom modulates allosterically human serum heme-albumin reactivity	176
Proteomica	176
Sviluppo di un modello cellulare della disfunzione mitocondriale nella malattia di Parkinson nella linea cellulare SH-SY5Y in seguito a trattamento con dopamina o MPP+ ed analisi proteomica dei profili di espressione proteica dei mitocondri in modelli di patologie neurodegenerative.	173
Heme-based catalytic properties of human serum albumin	172
Biomarkers of Parkinson’s disease	171
Reversible two-step unfolding of heme-human serum albumin: a H-1-NMR relaxometric and circular dichroism study	170
H-1 and O-17-NMR relaxometric investigations of paramagnetic contrast agents for MRI. Clues for higher relaxivities	170
Update of the Functional Mitochondrial Human Proteome Network	169
Totale	21.189

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	142.889
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	142.889

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	2.062	0	403	166	84	109	77	145	114	113	308	211	332
2022/2023	3.277	311	194	268	345	224	645	10	459	484	118	137	82
2023/2024	4.722	751	762	748	838	931	248	34	148	114	25	20	103
2024/2025	3.381	18	44	587	98	111	187	162	282	366	410	275	841
2025/2026	7.432	449	456	305	974	825	438	1.558	448	946	487	330	216
2026/2027	740	349	391	0	0	0	0	0	0	0	0	0	0
Totale													36.620